GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » EPS without NRI

Huadong Medicine Co (SZSE:000963) EPS without NRI : ¥1.70 (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co EPS without NRI?

Huadong Medicine Co's earnings per share without non-recurring items for the three months ended in Mar. 2024 was ¥0.49. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.70.

During the past 12 months, Huadong Medicine Co's average earnings per share (NRI) Growth Rate was 15.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 4.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 2.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Huadong Medicine Co's EPS without NRI or its related term are showing as below:

SZSE:000963' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -17   Med: 22.55   Max: 90.7
Current: 4

During the past 13 years, Huadong Medicine Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 90.70% per year. The lowest was -17.00% per year. And the median was 22.55% per year.

SZSE:000963's 3-Year EPS without NRI Growth Rate is ranked worse than
58.04% of 846 companies
in the Drug Manufacturers industry
Industry Median: 9.2 vs SZSE:000963: 4.00

Huadong Medicine Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.49. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.68.

Huadong Medicine Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.49. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.68.


Huadong Medicine Co EPS without NRI Historical Data

The historical data trend for Huadong Medicine Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co EPS without NRI Chart

Huadong Medicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.47 1.39 1.25 1.38 1.56

Huadong Medicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.41 0.44 0.37 0.49

Competitive Comparison of Huadong Medicine Co's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huadong Medicine Co's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's PE Ratio without NRI falls into.



Huadong Medicine Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huadong Medicine Co  (SZSE:000963) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Huadong Medicine Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Huadong Medicine Co (SZSE:000963) Business Description

Traded in Other Exchanges
N/A
Address
468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.
Executives
He Ru Fen Supervisors
Hu Bao Zhen Supervisors
Zhou Shun Hua Executives
Shao Ling Min Supervisors
Wan Ling Ling Executives
Fu Hang Director
Yue Jin Director
Chen Bo Secretary Dong
Qin Yun Supervisors
Li Bang Liang Directors, executives
Zhou Jin Bao Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines